ISCOMATRIX vaccines mediate CD8(+) T-cell cross-priming by a MyD88-dependent signaling pathway

Generating a cytotoxic CD8(+) T-cell response that can eradicate malignant cells is the primary objective of cancer vaccine strategies. In this study we have characterized the innate and adaptive immune response to the ISCOMATRIX adjuvant, and the ability of vaccine antigens formulated with this adj...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Nicholas S, Yang, Becky, Morelli, Adriana Baz, Koernig, Sandra, Yang, Annie, Loeser, Stefanie, Airey, Denise, Provan, Larissa, Hass, Phil, Braley, Hal, Couto, Suzana, Drane, Debbie, Boyle, Jeff, Belz, Gabrielle T, Ashkenazi, Avi, Maraskovsky, Eugene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3365289/
https://www.ncbi.nlm.nih.gov/pubmed/21894173
http://dx.doi.org/10.1038/icb.2011.71

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3365289/
https://www.ncbi.nlm.nih.gov/pubmed/21894173
http://dx.doi.org/10.1038/icb.2011.71

Ejemplares similares